Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients

Fibroblast growth factor 21 (FGF21) is identified as a potential biomarker for liver diseases. However, information is limited regarding serum FGF21 and impaired liver function in hyperthyroidism. We aim to determine the potential association of serum FGF21 levels with impaired liver enzymes in hype...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Xiao, Fangsen, Zeng, Jinyang, Huang, Peiying, Yan, Bing, Zeng, Xin, Liu, Changqin, Shi, Xiulin, Wang, Liying, Song, Haiqu, Lin, Mingzhu, Yang, Shuyu, Li, Zhibin, Li, Xuejun, Liu, Chao
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339876/
https://ncbi.nlm.nih.gov/pubmed/30692965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00800
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars